🔴 PODD is trading 6.7% down today after Omnipod recall and $50 million financial impact

PODD is trading 6.7% down at $143.52 following a voluntary recall of certain Omnipod insulin delivery system lots and an estimated $50 million financial impact.

• The company stated the recall could create a $50 million financial hit, which serves as the primary catalyst for the downward move.
• Selling pressure has intensified during the regular session after the stock initially dropped 5.1% in pre-market trading.
• The decline appears to be company-specific, as broader markets were trading only slightly higher at the time of the announcement.